These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11964110)

  • 21. Long-term benzodiazepine use and depression.
    Nathan RG; Robinson D; Cherek DR; Davison S; Sebastian S; Hack M
    Am J Psychiatry; 1985 Jan; 142(1):144-5. PubMed ID: 2857068
    [No Abstract]   [Full Text] [Related]  

  • 22. Physician Withdrawal Checklist (PWC-20).
    Rickels K; Garcia-Espana F; Mandos LA; Case GW
    J Clin Psychopharmacol; 2008 Aug; 28(4):447-51. PubMed ID: 18626273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A controlled trial of ondansetron, a 5-HT3 antagonist, in benzodiazepine discontinuation.
    Romach MK; Kaplan HL; Busto UE; Somer G; Sellers EM
    J Clin Psychopharmacol; 1998 Apr; 18(2):121-31. PubMed ID: 9555597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anxiety or depression during withdrawal of hypnotic treatments.
    Lader M
    J Psychosom Res; 1994; 38 Suppl 1():113-23; discussion 118-23. PubMed ID: 7799243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Withdrawal from long-term benzodiazepine use: randomised trial in family practice.
    Vicens C; Fiol F; Llobera J; Campoamor F; Mateu C; Alegret S; Socías I
    Br J Gen Pract; 2006 Dec; 56(533):958-63. PubMed ID: 17132385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzodiazepine withdrawal phenomena.
    Hallstrom C; Lader M
    Int Pharmacopsychiatry; 1981; 16(4):235-44. PubMed ID: 6121767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of alpidem and placebo in relieving benzodiazepine withdrawal symptoms.
    Lader M; Farr I; Morton S
    Int Clin Psychopharmacol; 1993; 8(1):31-6. PubMed ID: 8097214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ["Depression and benzodiazepine dependence in the elderly"].
    Kolitzus H
    Psychiatr Prax; 1995 Nov; 22(6):263. PubMed ID: 8570761
    [No Abstract]   [Full Text] [Related]  

  • 29. Benzodiazepine tapering: a prospective study.
    Vikander B; Koechling UM; Borg S; Tönne U; Hiltunen AJ
    Nord J Psychiatry; 2010 Aug; 64(4):273-82. PubMed ID: 20629611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation.
    Rickels K; Schweizer E; Case WG; Greenblatt DJ
    Arch Gen Psychiatry; 1990 Oct; 47(10):899-907. PubMed ID: 2222129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failure of buspirone to manage benzodiazepine withdrawal.
    Schweizer E; Rickels K
    Am J Psychiatry; 1986 Dec; 143(12):1590-2. PubMed ID: 2878622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of benzodiazepine dependence in alcohol and drug dependent outpatients: a research report.
    Kan CC; Breteler MH; van der Ven AH; Timmermans MA; Zitman FG
    Subst Use Misuse; 2001 Jun; 36(8):1085-109. PubMed ID: 11504154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review: Adjunctive pharmacologic approaches for benzodiazepine tapers.
    Welsh JW; Tretyak V; McHugh RK; Weiss RD; Bogunovic O
    Drug Alcohol Depend; 2018 Aug; 189():96-107. PubMed ID: 29906718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electroacupuncture for tapering off long-term benzodiazepine use: study protocol of randomized controlled trial.
    Yeung WF; Chung KF; Zhang ZJ; Chan WC; Zhang SP; Ng RM; Chan CL; Ho LM; Yu YM; Lao LX
    BMC Complement Altern Med; 2017 Mar; 17(1):183. PubMed ID: 28359309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychometric evaluation of the 10-item Short Opiate Withdrawal Scale-Gossop (SOWS-Gossop) in patients undergoing opioid detoxification.
    Vernon MK; Reinders S; Mannix S; Gullo K; Gorodetzky CW; Clinch T
    Addict Behav; 2016 Sep; 60():109-16. PubMed ID: 27124502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users.
    Mintzer MZ; Stoller KB; Griffiths RR
    Psychopharmacology (Berl); 1999 Nov; 147(2):200-9. PubMed ID: 10591888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregabalin as adjunctive therapy in benzodiazepine discontinuation.
    Caniff K; Telega E; Bostwick JR; Gardner KN
    Am J Health Syst Pharm; 2018 Jan; 75(2):67-71. PubMed ID: 29317396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinic.
    Nakao M; Takeuchi T; Nomura K; Teramoto T; Yano E
    Psychiatry Clin Neurosci; 2006 Oct; 60(5):605-10. PubMed ID: 16958945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of discontinuing chronic benzodiazepine use in nursing home residents: a pilot study.
    Bourgeois J; Elseviers MM; Van Bortel L; Petrovic M; Vander Stichele RH
    Eur J Clin Pharmacol; 2014 Oct; 70(10):1251-60. PubMed ID: 25098683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.